| News

This is custom heading element

05.11.2019

Which problem does your company aim to solve?

Crevoisier (img: Dave Joly)

Yann Duscher, Crevoisier: Crevoisier wants to provide equipment that increases the productivity and quality rates of its customers.

When and why did you found your company?

Crevoisier was founded in 1966 in order to provide quality mechanical parts.

What does winning the i4Challenge mean to you?

It’s a great reward, especially for the company, the team and all the people who have worked hard to make this ambitious project succeed. It also translates into personal satisfaction because it proves the quality of our work and that we had the correct vision by innovating in the area of 4.0 and including collaborative robots in our next step.

What does the term “Industry 4.0” mean to you and why is the topic relevant?

Industry 4.0 corresponds to equipment connectivity and data evaluation. The topic is important because it is the continuation, the evolution of the industry: Interconnection, production monitoring, machines that are linked to each other, and competent people who can monitor their production, who can intervene early enough if there is an issue and are able to change the manner of intervention to make it happen. Production monitoring is extremely important today. You can control it from home by using a computer, you can talk and interact with the machines, you can involve people from all over the world, so Industry 4.0 is the future, it’s the industry of today.

Where do you see the development in the region?

Generally speaking, concrete solutions exist in the region, from software and connected machines to cobotics. However, there is a lack of qualified personnel to develop and integrate its solutions and this is really slowing down our economy.

What are your plans for your company?

We want to build a new factory to consolidate our four sites under the same roof. In addition, we are currently producing a new type of machines which will soon be available.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Novartis Campus
Basel Area Business & Innovation, Switzerland Innovation Park

Switzerland Innovation Park Basel Area Site Novartis Campus

We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.

Read More
Basel Area Business & Innovation, Switzerland Innovation Park

The innovation and enterprise campus GRID is filling up

Two institutes from the University of Basel and a pharmaceutical company are relocating to the GRID innovation and enterprise campus, which is currently under construction at BaseLink in Allschwil. The new building will also contain the headquarters of the Switzerland Innovation Park Basel Area in future.

Read More
Basel Area Business & Innovation, Innovation

Artidis ends successful study

Artidis, a startup from Basel, has developed a nanotechnology platform that can be used for cancer diagnosis, among other things. The platform has now been tested in a study that was able to achieve its primary endpoint.

Read More
Basel Area Business & Innovation, Innovation

Startup Academy celebrates anniversary

Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.

Read More
Basel Area Business & Innovation, Invest

Syngenta grows strongly and stays true to Basel

Syngenta AG, Adama and Sinochem are to be united under the umbrella of the new Syngenta Group. The group is headquartered in Basel and employs around 48,000 staff across over 100 countries.

Read More
Basel Area Business & Innovation, Innovation

Tolremo raises additional funding

The Muttenz-based biotechnology company Tolremo Therapeutics has raised an additional 4.7 million Swiss francs as part of a financing round. The company develops cancer therapies for precision medicine and is now driving forward clinical development.

Read More
Ruben Herrendorff, CEO Polyneuron Pharmaceuticals
Basel Area Business & Innovation, Innovation

Polyneuron medication receives orphan drug status in the USA

The American health authority has granted Polyneuron’s drug PN-1007 orphan designation. This status uses special conditions to balance out commercial disadvantages when developing drugs for rare diseases.

Read More
Basel Area Business & Innovation, Innovation

BaseLaunch Applications open

BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.

Read More
Basel Area Business & Innovation, Innovation

i4Challenge Applications open

The i4Challenge is an acceleration program for SME, startups and new projects focused on innovative solutions, new approaches and next-generation products or services for Industry 4.0.

Read More
Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
1 2 3 19

Do you have a question? We'd like to hear from you.